SPDR S&P Biotech ETF $XBI Stake Raised by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 429.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,853 shares of the exchange traded fund’s stock after buying an additional 22,588 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in SPDR S&P Biotech ETF were worth $4,311,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in XBI. Axiom Investment Management LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $26,000. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $27,000. Angeles Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $28,000. SHP Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $31,000. Finally, Morling Financial Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $36,000.

SPDR S&P Biotech ETF Trading Up 2.5%

XBI opened at $147.86 on Tuesday. The stock has a market cap of $10.21 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1 year low of $106.30 and a 1 year high of $169.89. The stock’s 50 day simple moving average is $157.89 and its 200-day simple moving average is $147.21.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.